Company ReShape Lifesciences Inc. Other OTC
Equities
RSLS
US7611236032
Advanced Medical Equipment & Technology
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Minimally Invasive Medical Devices
100.0
%
| 11 | 100.0 % | 9 | 100.0 % | -22.79% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
82.2
%
| 9 | 82.1 % | 7 | 82.2 % | -22.71% |
Europe
11.0
%
| 1 | 11.1 % | 1 | 11.0 % | -23.64% |
Australia
6.1
%
| 1 | 6.1 % | 1 | 6.1 % | -23.55% |
Rest of World
0.7
%
| 0 | 0.6 % | 0 | 0.7 % | -11.43% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Paul Hickey
CEO | Chief Executive Officer | 59 | 01/20/01 |
Director of Finance/CFO | 63 | 15/21/15 | |
Dov Gal
CMP | Compliance Officer | - | - |
Al Diaz
COO | Chief Operating Officer | - | 31/21/31 |
Nick Ansari
PRN | Corporate Officer/Principal | 62 | 06/22/06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Blackford
BRD | Director/Board Member | 66 | 01/16/01 |
Dan Gladney
CHM | Chairman | 70 | 01/15/01 |
Director/Board Member | 70 | 15/21/15 | |
Paul Hickey
CEO | Chief Executive Officer | 59 | 01/20/01 |
Lori McDougal
BRD | Director/Board Member | 62 | 01/15/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 95,388 | 0 | 0 | 88.83 % |
Stock B | 1 | 23,457,090 | 20,838,013 ( 88.83 %) | 0 |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+7.01% | 22TCr | |
+11.01% | 19TCr | |
+19.20% | 14TCr | |
+30.79% | 11TCr | |
+1.48% | 6.46TCr | |
+13.95% | 5.24TCr | |
-0.16% | 4.85TCr | |
-6.20% | 3.8TCr | |
+0.91% | 3.56TCr |